Key result
The ACS:180 cardiac troponin I assay was equally efficient to CK-MB and cTnT for diagnosing acute myocardial infarction and identifying high-risk unstable angina.
Why the study?
Does the ACS:180 cardiac troponin I assay perform as well as other cardiac biomarkers in diagnosing acute myocardial infarction and identifying high-risk unstable angina?
Population
Patients admitted to the coronary care unit with suspected acute coronary syndromes, and a separate group of…
Comparison
ACS:180 cardiac troponin I (cTnI) assay vs Creatine kinase, cardiac troponin T, myoglobin…
Design
Cohort
Follow-up
12 hours
Authors
Loading...
Supports troponin I assay use in suspected ACS; leaves open need for validation against modern high-sensitivity assays.
Observational
Does the ACS:180 cardiac troponin I assay perform as well as other cardiac biomarkers in diagnosing acute myocardial infarction and identifying high-risk unstable angina?
The ACS:180 cardiac troponin I assay is as efficient as CK-MB and cTnT for diagnosing acute myocardial infarction and risk-stratifying unstable angina.
Collinson et al. (2001) conducted an observational in Suspected acute coronary syndromes. ACS:180 cardiac troponin I assay vs. CK-MB and cTnT assays was evaluated on Diagnosis of acute myocardial infarction. The ACS:180 cardiac troponin I assay was equally efficient to CK-MB and cTnT for diagnosing acute myocardial infarction and identifying high-risk unstable angina.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: